Twinbeech Capital LP Makes New $68.74 Million Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Twinbeech Capital LP bought a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the 4th quarter, HoldingsChannel reports. The fund bought 135,881 shares of the healthcare conglomerate’s stock, valued at approximately $68,737,000. UnitedHealth Group accounts for about 1.2% of Twinbeech Capital LP’s investment portfolio, making the stock its 8th biggest holding.

Other large investors have also modified their holdings of the company. NewSquare Capital LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth $26,000. Hurley Capital LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth $28,000. Aster Capital Management DIFC Ltd purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth $30,000. Finally, AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth $30,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,533 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 14th. The stock was purchased at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the transaction, the director now directly owns 6,033 shares in the company, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director John H. Noseworthy bought 300 shares of the company’s stock in a transaction on Wednesday, May 14th. The stock was bought at an average cost of $312.16 per share, with a total value of $93,648.00. Following the completion of the acquisition, the director now owns 6,063 shares of the company’s stock, valued at $1,892,626.08. This represents a 5.21% increase in their position. The disclosure for this purchase can be found here. Insiders bought a total of 109,408 shares of company stock worth $31,607,768 over the last 90 days. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH opened at $291.24 on Monday. UnitedHealth Group Incorporated has a fifty-two week low of $248.88 and a fifty-two week high of $630.73. The company has a market capitalization of $264.20 billion, a price-to-earnings ratio of 18.79, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56. The firm has a 50-day simple moving average of $470.82 and a 200-day simple moving average of $513.25. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same quarter last year, the company posted $6.91 EPS. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 2.88%. UnitedHealth Group’s payout ratio is currently 35.18%.

Analyst Upgrades and Downgrades

Several research firms recently commented on UNH. JPMorgan Chase & Co. dropped their target price on UnitedHealth Group from $525.00 to $405.00 and set an “overweight” rating on the stock in a report on Thursday. Bank of America lowered UnitedHealth Group from a “buy” rating to a “neutral” rating and dropped their target price for the company from $560.00 to $350.00 in a report on Wednesday, May 14th. Hsbc Global Res lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Tuesday, April 22nd. Erste Group Bank lowered UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, April 30th. Finally, StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Six equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $486.00.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.